2005
DOI: 10.1016/j.ijom.2005.03.004
|View full text |Cite
|
Sign up to set email alerts
|

The effect of the antibody used and method of quantification on oral mucosal vascularity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
3
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 16 publications
1
3
0
Order By: Relevance
“…We did not find any difference (data not shown) in density, area, and perimeter when analyzed site wise (buccal mucosa, tongue and others). This is similar to a previous study, in which anatomical site showed no difference in MVD using vWF [19]. Hence, it is less likely that our results are affected by inclusion of carcinomas of different oral sites.…”
Section: Angiogenesis and Metastasissupporting
confidence: 92%
See 1 more Smart Citation
“…We did not find any difference (data not shown) in density, area, and perimeter when analyzed site wise (buccal mucosa, tongue and others). This is similar to a previous study, in which anatomical site showed no difference in MVD using vWF [19]. Hence, it is less likely that our results are affected by inclusion of carcinomas of different oral sites.…”
Section: Angiogenesis and Metastasissupporting
confidence: 92%
“…Others [19] recommend use of vWF. Within paraffin embedded tissues vWF is more potent than CD31 [19][20] or a close correlation exists between vWF and CD34/ CD31 staining [21][22]. Irrespective of methodology, MVD in seven out of 10 studies with vWF showed no relation to LN status (Table 5).…”
Section: Angiogenesis and Metastasismentioning
confidence: 99%
“…Different methods are available for the evaluation of angiogenesis in biologic material, including MVC and the determination of microvessel density and volume. [36][37][38] Among these methods, MVC is an easy technique that has prognostic relevance in different tumors. 38,39 One widely used angiogenic marker is endoglin, or CD105, which was originally identified as a human endothelial marker although subsequent studies demonstrated that this cell surface antigen is also expressed by macrophages, erythrocyte precursors, and stromal cells.…”
Section: Discussionmentioning
confidence: 99%
“…20 In this manner, it is possible to indirectly establish the angiogenic activity of a tissue. 20,21 To our knowledge, there are no studies analyzing the expression of VEGF in PGs, RCs, and RRCs. Therefore, the aim of the present study was to assess and compare the immunoexpression of VEGF in these lesions, relating it to the angiogenic index and the intensity of the inflammatory infiltrate.…”
mentioning
confidence: 99%